Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities.

Hatzichristou D, d'Anzeo G, Porst H, Buvat J, Henneges C, Rossi A, Hamidi K, Büttner H

Open source

DOI
10.1186/s12894-015-0107-5
Published
2015 Nov 12
Container
BMC urology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12894-015-0107-5,
  title = {Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities.},
  author = {Hatzichristou D and d'Anzeo G and Porst H and Buvat J and Henneges C and Rossi A and Hamidi K and Büttner H},
  year = {2015},
  journal = {BMC urology},
  doi = {10.1186/s12894-015-0107-5},
  url = {https://doi.org/10.1186/s12894-015-0107-5}
}

RIS

TY  - JOUR
TI  - Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities.
AU  - Hatzichristou D
AU  - d'Anzeo G
AU  - Porst H
AU  - Buvat J
AU  - Henneges C
AU  - Rossi A
AU  - Hamidi K
AU  - Büttner H
PY  - 2015
JO  - BMC urology
DO  - 10.1186/s12894-015-0107-5
UR  - https://doi.org/10.1186/s12894-015-0107-5
ER  - 

APA

D, H., G, D., H, P., J, B., C, H., A, R., K, H., & H, B. (2015). Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities.. BMC urology. https://doi.org/10.1186/s12894-015-0107-5

Source records